Fig. 6: Assessment of the overall survival according to p32/c1qbp expression in patients with melanoma. | Cell Death & Disease

Fig. 6: Assessment of the overall survival according to p32/c1qbp expression in patients with melanoma.

From: p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment

Fig. 6

A Survival plot data (Kaplan–Meier plot; UCSC Xena browse tool) downloaded from TCGA Melanoma datasets illustrates better survival among melanoma patients (n = 481) with lower p32/c1qbp expression levels. B Immunohistochemical analysis of p32 in human melanoma tissue microarray containing normal and malignant melanoma tissue sections. C Immunohistochemical analysis of pAKT in human melanoma TMA containing normal and malignant melanoma. All data are represented as mean ± SD. Student’s t-test was used for all statistical analyses, n = 3 (****P < 0.0001).

Back to article page